Taconic Biosciences' Dr. Jochen Welcker was recently interviewed by Drug Discovery News about utilizing CRISPR for gene editing, and specifically highlights the Easi-CRISPR technology used for model generation. Researchers know that there are numerous gene editing technologies available for creating genetically engineered models (GEMs), however, Easi-CRISPR has the unique capability to insert longer sequences than traditional CRISPR such as entire human or reporter genes as well as genomic replacements:
"Scientists at the University of California, San Francisco (UCSF)--along with researchers at Mammoth Biosciences--have developed what they say is an inexpensive new test that can rapidly diagnose COVID-19 infections.
The partners say that the new test--officially named the SARS-CoV-2 DETECTR--is easy to implement and to interpret, and requires no specialized equipment, which could make the test more widely available than the current crop of COVID-19 test kits, if it were to receive regulatory approval--UCSF researchers are clinically validating the test in an effort to fast-track the approval through the emergency use authorization path."
Read more from Dr. Welcker's interview at: drugdiscoverynews.com
"Scientists at the University of California, San Francisco (UCSF)--along with researchers at Mammoth Biosciences--have developed what they say is an inexpensive new test that can rapidly diagnose COVID-19 infections. The partners say that the new test--officially named the SARS-CoV-2 DETECTR--is easy to implement and to interpret, and requires no specialized equipment, which could make the test more widely available than the current crop of COVID-19 test kits, if it were to receive regulatory approval--UCSF researchers are clinically validating the test in an effort to fast-track the approval through the emergency use authorization path."